Literature DB >> 11511683

Prolyl 4-hydroxylase isoenzymes I and II have different expression patterns in several human tissues.

R Nissi1, H Autio-Harmainen, P Marttila, R Sormunen, K I Kivirikko.   

Abstract

Prolyl 4-hydroxylase plays a central role in the synthesis of all collagens. We have previously reported that the recently identified Type II isoenzyme is its main form in chondrocytes and possibly in capillary endothelial cells, while Type I is the main form in many other cell types. We report here that the Type II isoenzyme is clearly the main form in capillary endothelial cells and also in cultured umbilical vein endothelial cells, whereas no Type I isoenzyme could be detected in these cells by immunostaining or Western blotting. The Type II isoenzyme was also the main form in cells of the developing glomeruli in the fetal kidney and tubular structures of collecting duct caliber in both fetal and adult kidney, in occasional sinusoidal structures and epithelia of the bile ducts in the liver, and in some cells of the decidual membrane that probably represented invasive cytotrophoblasts in the placenta. Osteoblasts in a fetal calvaria, i.e., a bone developing by intramembranous ossification, stained strongly for both types of isoenzyme. The Type I isoenzyme was the main form in undifferentiated interstitial mesenchymal cells of the developing kidney, for example, and in fibroblasts and fibroblastic cells in many tissues. Skeletal myocytes and smooth muscle cells appeared to have the Type I isoenzyme as their only prolyl 4-hydroxylase form. Hepatocytes expressed small amounts of the Type I enzyme and very little if any Type II, the Type I expression being increased in malignant hepatocytes and cultured hepatoblastoma cells. The data suggest that the Type I isoenzyme is expressed especially by cells of mesenchymal origin and in developing and malignant tissues, whereas the Type II isoenzyme is expressed, in addition to chondrocytes and osteoblasts, by more differentiated cells, such as endothelial cells and cells of epithelial structures. (J Histochem Cytochem 49:1143-1153, 2001)

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11511683     DOI: 10.1177/002215540104900908

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  13 in total

1.  Defective p53 antiangiogenic signaling in glioblastoma.

Authors:  Benjamin Berger; David Capper; Dieter Lemke; Philipp-Niclas Pfenning; Michael Platten; Michael Weller; Andreas von Deimling; Wolfgang Wick; Markus Weiler
Journal:  Neuro Oncol       Date:  2010-05-26       Impact factor: 12.300

2.  Macrophage-like synoviocytes display phenotypic polymorphisms in a serum-free tissue-culture medium.

Authors:  Matthias F Seidel; Franz-Walter Koch; Hans Vetter
Journal:  Rheumatol Int       Date:  2004-12-10       Impact factor: 2.631

3.  Regulation of type II collagen synthesis during osteoarthritis by prolyl-4-hydroxylases: possible influence of low oxygen levels.

Authors:  Claudia Grimmer; Nadine Balbus; Ute Lang; Thomas Aigner; Thorsten Cramer; Lutz Müller; Bernd Swoboda; David Pfander
Journal:  Am J Pathol       Date:  2006-08       Impact factor: 4.307

4.  Severe Extracellular Matrix Abnormalities and Chondrodysplasia in Mice Lacking Collagen Prolyl 4-Hydroxylase Isoenzyme II in Combination with a Reduced Amount of Isoenzyme I.

Authors:  Ellinoora Aro; Antti M Salo; Richa Khatri; Mikko Finnilä; Ilkka Miinalainen; Raija Sormunen; Outi Pakkanen; Tiina Holster; Raija Soininen; Carina Prein; Hauke Clausen-Schaumann; Attila Aszódi; Juha Tuukkanen; Kari I Kivirikko; Ernestina Schipani; Johanna Myllyharju
Journal:  J Biol Chem       Date:  2015-05-22       Impact factor: 5.157

5.  Molecular Cloning, Characterization, and Expression Analysis of a Prolyl 4-Hydroxylase from the Marine Sponge Chondrosia reniformis.

Authors:  Marina Pozzolini; Sonia Scarfì; Francesca Mussino; Sara Ferrando; Lorenzo Gallus; Marco Giovine
Journal:  Mar Biotechnol (NY)       Date:  2015-04-28       Impact factor: 3.619

6.  P4HA1 mutations cause a unique congenital disorder of connective tissue involving tendon, bone, muscle and the eye.

Authors:  Yaqun Zou; Sandra Donkervoort; Antti M Salo; A Reghan Foley; Aileen M Barnes; Ying Hu; Elena Makareeva; Meganne E Leach; Payam Mohassel; Jahannaz Dastgir; Matthew A Deardorff; Ronald D Cohn; Wendy O DiNonno; Fransiska Malfait; Monkol Lek; Sergey Leikin; Joan C Marini; Johanna Myllyharju; Carsten G Bönnemann
Journal:  Hum Mol Genet       Date:  2017-06-15       Impact factor: 6.150

7.  TNF-alpha suppresses prolyl-4-hydroxylase alpha1 expression via the ASK1-JNK-NonO pathway.

Authors:  Cheng Zhang; Ming-Xiang Zhang; Ying H Shen; Jared K Burks; Yun Zhang; Jian Wang; Scott A LeMaire; Koichi Yoshimura; Hiroki Aoki; Joseph S Coselli; Xing Li Wang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2007-05-03       Impact factor: 8.311

8.  Human prolyl-4-hydroxylase alpha(I) transcription is mediated by upstream stimulatory factors.

Authors:  Li Chen; Ying H Shen; Xinwen Wang; Jing Wang; Yehua Gan; Nanyue Chen; Jian Wang; Scott A LeMaire; Joseph S Coselli; Xing Li Wang
Journal:  J Biol Chem       Date:  2006-02-17       Impact factor: 5.157

Review 9.  Inhibition of tumor angiogenesis by p53: a new role for the guardian of the genome.

Authors:  Jose G Teodoro; Sara K Evans; Michael R Green
Journal:  J Mol Med (Berl)       Date:  2007-06-23       Impact factor: 4.599

10.  Structural enzymology binding studies of the peptide-substrate-binding domain of human collagen prolyl 4-hydroxylase (type-II): High affinity peptides have a PxGP sequence motif.

Authors:  Abhinandan V Murthy; Ramita Sulu; M Kristian Koski; Hongmin Tu; Jothi Anantharajan; Shiv K Sah-Teli; Johanna Myllyharju; Rik K Wierenga
Journal:  Protein Sci       Date:  2018-09       Impact factor: 6.725

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.